cigna glp 1 2025 Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss Online Weight Loss Covered by

Of the two main incretin hormones released with food ingestion, the actions of glucagon-like peptide-1 (GLP-1) have been exploited for therapeutic benefit

Water and HFHS food were available ad libitum throughout the study period

The result is harder, drier stool that becomes difficult to pass

Selecting a GLP-1 requires informed conversation with a qualified healthcare provider about personal risk factors, contraindications, and tolerance expectations

Patients often say the team responds quickly and helps with titration questions or side effect concerns

A review published in the journal Diabetes Care found an increased risk of pancreatitis in patients using GLP-1 receptor agonists like Ozempic, although the absolute risk remains low